跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
息宁 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Carbidopa and Levodopa Sustained-release Tablets
Approved
化学药品
Carbidopa and Levodopa Sustained-release Tablets
Organon Healthcare GmbH
🇨🇳 National Medical Products Administration
Approval Date
Oct 27, 2021
Approval ID
8CYnEkiwthM
Company
Organon Healthcare GmbH
Type
化学药品
Approval Details
Approval Id
8CYnEkiwthM
Approval Number
国药准字HJ20160372
Generic Name
卡左双多巴缓释片
Generic Name En
Carbidopa and Levodopa Sustained-release Tablets
Trade Name
息宁
Brand Name
息宁
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含卡比多巴50mg（按C₁₀H₁₄N₂O₄计）和左旋多巴0.2g
Reg Date
2021-10-27
Expired Date
2026-10-26
Company Name
Organon Healthcare GmbH
Company Detail Path
/organization/organon-healthcare-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 27, 2021
Approval ID
8CYnEkiwthM
Type
化学药品
Back to NMPA Approvals
